2020-001053-44: Stabilization of atherosclerosis in carotid artery by Rivaroxaban as evaluated by 3D ultrasound with contrast |
|
|
| Not yet recruiting | 4 | 62 | Europe | Film-coated tablet, Xarelto® | Rigshospitalet, Department of Vascular Surgery, Bayer AG | Patients with - Stable peripheral artery diseaseand- Asymptomatic, atherosclerotic plaque/stenosis in the carotid artery; asymptomatic regarding cerebral ischaemia including stroke and transient ischaemic attack (TIA) or amaurosis fugax. Patienter med - Stabil perifer arteriel sygdomog - Asymptomatisk, aterosklerotisk plaque/stenose in carotis; asymptomatisk vedr. iskæmisk apopleksi inkluderende stroke og transient cerebral iskæmi (TCI) eller amaurosis fugax., Patients with: - Atherosclerosis in limb arteries and - Atherosclerosis in carotid artery with no symptoms of major or minor stroke or temporary vision loss. Patienter med:- Åreforkalkning i underekstremitets blodkarog- Åreforkalkning i halspulsåren uden symptomer på slagtilfælde eller forbigående synstab., Diseases [C] - Cardiovascular Diseases [C14] | | | | |
SPIRIT, NCT05797376: Effects of aSPIrin Versus Aspirin Plus Low-dose RIvaroxaban on Carotid aTherosclerotic Plaque Inflammation |
|
|
| Recruiting | 4 | 92 | RoW | Rivaroxaban 2.5mg, Xarelto 2.5mg | Asan Medical Center, Bayer | Atherosclerosis of Artery, Coronary Artery Disease, Peripheral Arterial Disease, Carotid Stenosis | 12/24 | 06/25 | | |
